Neuropathogenic Studies of Congenital Disorders of Glycosylation
Neuropathogenic Studies of Congenital Disorders of Glycosylation
批准号:
9979478
负责人:
Zhaolan Zhou
金额:
$44.6万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2022-12-31
关键词:
AddressAdoptedAdultAllelesAnimal ModelAtaxiaAtrophicBehavioralBlood Coagulation DisordersBrainCell physiologyCellsCerebellar NucleiCerebellar degenerationCerebellumCharacteristicsChildhoodCommunitiesCongenital cerebellar hypoplasiaCongenital disorders of glycosylationDevelopmentDiagnosisDiseaseDisorder of neurometabolic regulationEmbryoEnterobacteria phage P1 Cre recombinaseEnzymesEpilepsyExhibitsExonsFailureFunctional disorderFutureGene DeliveryGenesGeneticGenetic DiseasesGrowthHeterozygoteImpairmentInjectionsIntellectual functioning disabilityInvestigationKnock-inKnowledgeLinkLoxP-flanked alleleMaintenanceMannoseMediatingMissense MutationModelingMolecularMonosaccharidesMorbidity - disease rateMusMutationNervous system structureNeurogliaNeurologicNeurologic DeficitNeuronsNonsense CodonOphthalmologyOrganPathogenesisPathogenicityPathologyPathway interactionsPatientsPharmacologyPhenotypePhosphomannomutaseProtein GlycosylationProteinsResearchResourcesRoleSeizuresSourceSymptomsTherapeuticTimeUrsidae Familyage relatedbasebehavioral phenotypingcell typeexperienceglycosylationimprovedinnovationinsightinterestlink proteinloss of functionmouse modelnovelpreclinical studyprogramsstroke-like episodetherapeutic developmenttool
中文摘要
先天性糖基化紊乱(CDG)是一组神经代谢紊乱,其特征是
高度保守的细胞糖基化机制中的遗传缺陷。大多数CDG患者
在PMM2中有双等位基因突变,PMM2是一种编码磷酸甘露聚糖酶2的基因,需要
激活甘露糖单糖进行N-连接蛋白糖基化。PMM2-CDG患者患有
多系统受累,所有患者都一致患有神经功能障碍,即
突出,进行性,会导致终生智力残疾,共济失调,并经常癫痫发作。基于
CDG的遗传学基础,我们建议建立并鉴定一种新的PMM2-CDG小鼠模型。
目的:研究PMM2在神经细胞和神经胶质细胞中的功能。我们还将调查
PMM2在小脑发育和功能中的作用结合了遗传、分子和
行为方法,我们希望不仅揭示CDG的致病机制的新见解,
而且还加快了以机制为基础的疗法的发展,以改善治疗。此外,
我们建议的研究将为广大研究界提供创新的工具和资源,以
研究各种糖基化缺陷相关疾病的病理生理学基础。
英文摘要
Congenital disorders of glycosylation (CDG) are a group of neurometabolic disorders characterized by
genetic defects in the highly conserved cellular glycosylation machinery. A majority of CDG patients
have biallelic mutations in PMM2, a gene encoding the protein phosphomannomutase 2 required to
activate mannose monosaccharides for N-linked protein glycosylation. PMM2-CDG patients suffer from
multi-systemic involvement, and all patients uniformly suffer from neurological impairment that is
prominent, progressive, and produces lifelong intellectual disability, ataxia and often seizures. Based on
the genetic basis of CDG, we propose to establish and characterize a novel mouse model of PMM2-CDG
to specifically investigate the function of PMM2 in neuronal and glial cells. We will also investigate the
role of PMM2 in cerebellum development and function. With combined genetic, molecular, and
behavioral approaches, we hope to not only reveal novel insight into the pathogenic mechanisms of CDG,
but also to expedite the development of mechanism-based therapeutics to improve treatment. Moreover,
our proposed study will provide the research community at large with innovative tools and resources to
investigate the pathophysiology underlying a variety of glycosylation deficit-related disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Models Core
-
批准号:10450698
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2021
-
负责人:Zhaolan Zhou
-
依托单位:
Preclinical Models Core
-
批准号:10678904
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2021
-
负责人:Zhaolan Zhou
-
依托单位:
Preclinical Models Core
-
批准号:10240004
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2021
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Epigenetic Mechanisms Underlying Stress-related Neuropsychiatric Disorders
-
批准号:10196918
-
项目类别:
-
资助金额:$54.65万
-
财政年份:2018
-
负责人:Zhaolan Zhou
-
依托单位:
Pathogenic Studies of CDKL5 Disorder
-
批准号:10371048
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2018
-
负责人:Zhaolan Zhou
-
依托单位:
Pathogenic Studies of CDKL5 Disorder
-
批准号:9893035
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2018
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Epigenetic Mechanisms Underlying Stress-Related Neuropsychiatric Disorders
-
批准号:9392597
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2017
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:8631489
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:10656152
-
项目类别:
-
资助金额:$52.03万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:8850004
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:8723314
-
项目类别:
-
资助金额:$34.01万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:9294173
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Understanding the Pathogenic Mechanisms of Rett Syndrome
-
批准号:10242844
-
项目类别:
-
资助金额:$51.93万
-
财政年份:2013
-
负责人:Zhaolan Zhou
-
依托单位:
Defining the Epigenetic Architecture Associated with Early-Life Stress
-
批准号:8471199
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Defining the Epigenetic Architecture Associated with Early-Life Stress
-
批准号:8123187
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Defining the Epigenetic Architecture Associated with Early-Life Stress
-
批准号:8004827
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Defining the Epigenetic Architecture Associated with Early-Life Stress
-
批准号:8666052
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Defining the Epigenetic Architecture Associated with Early-Life Stress
-
批准号:8299100
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Phenotypic Characterization of MECP2 Mice
-
批准号:8038922
-
项目类别:
-
资助金额:$4.41万
-
财政年份:2010
-
负责人:Zhaolan Zhou
-
依托单位:
Neuronal Activity-dependent Regulation of MeCP2 Function
-
批准号:7243765
-
项目类别:
-
资助金额:$8.66万
-
财政年份:2007
-
负责人:Zhaolan Zhou
-
依托单位:
海外基金